 Uterine Cervical Dysplasia
"Uterine Cervical Dysplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.
| Descriptor ID |
D002578
|
| MeSH Number(s) |
C04.834.818 C13.351.500.852.593.074
|
| Concept/Terms |
Uterine Cervical Dysplasia- Uterine Cervical Dysplasia
- Cervical Dysplasia, Uterine
- Dysplasia, Uterine Cervical
- Cervix Dysplasia
- Dysplasia, Cervix
|
Below are MeSH descriptors whose meaning is more general than "Uterine Cervical Dysplasia".
Below are MeSH descriptors whose meaning is more specific than "Uterine Cervical Dysplasia".
This graph shows the total number of publications written about "Uterine Cervical Dysplasia" by people in UAMS Profiles by year, and whether "Uterine Cervical Dysplasia" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 2 | 0 | 2 | | 2021 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2017 | 3 | 0 | 3 | | 2016 | 2 | 0 | 2 | | 2015 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2013 | 4 | 1 | 5 | | 2011 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2007 | 3 | 2 | 5 | | 2006 | 3 | 0 | 3 | | 2005 | 1 | 1 | 2 | | 2004 | 3 | 0 | 3 | | 2003 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 1998 | 1 | 0 | 1 | | 1995 | 1 | 0 | 1 | | 1993 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Uterine Cervical Dysplasia" by people in Profiles over the past ten years.
-
Wheeler CM, Torrez-Martinez NE, Torres-Chavolla E, Parvu V, Andrews JC, Du R, Robertson M, Joste NE, Cuzick J. Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States. Am J Obstet Gynecol. 2024 02; 230(2):243.e1-243.e11.
-
Cuzick J, Adcock R, Kinney W, Castle PE, Robertson M, McDonald RM, Stoler MH, Du R, Wheeler CM. Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States. Int J Cancer. 2023 07 01; 153(1):83-93.
-
Guo M, Shlyakhova N, Khanna A, Tinnirello AA, Schmeler KM, Hwang J, Sturgis EM, Stewart J. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening. J Am Soc Cytopathol. 2021 Jul-Aug; 10(4):399-405.
-
Singh AP, Jeffus SK, Shalin SC. Cervical dysplasia in a patient with inherited epidermodysplasia verruciformis-A mere coincidence? J Cutan Pathol. 2021 Jun; 48(6):763-770.
-
Benard VB, Castle PE, Jenison SA, Hunt WC, Kim JJ, Cuzick J, Lee JH, Du R, Robertson M, Norville S, Wheeler CM. Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era. JAMA Oncol. 2017 Jun 01; 3(6):833-837.
-
Rader JS, Sill MW, Beumer JH, Lankes HA, Benbrook DM, Garcia F, Trimble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA, Spirtos NM, Byron J, Thaker PH, Lele S, Alberts D. A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 05; 145(2):291-297.
-
Liu P, Iden M, Fye S, Huang YW, Hopp E, Chu C, Lu Y, Rader JS. Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):642-650.
-
Levy RA, Kumarapeli AR, Spencer HJ, Quick CM. Cervical polyps: Is histologic evaluation necessary? Pathol Res Pract. 2016 Sep; 212(9):800-3.
-
Lim AW, Hollingworth A, Kalwij S, Curran G, Sasieni P. Offering self-sampling to cervical screening non-attenders in primary care. J Med Screen. 2017 03; 24(1):43-49.
-
Nakagawa M, Greenfield W, Moerman-Herzog A, Coleman HN. Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines. Clin Vaccine Immunol. 2015 Jul; 22(7):679-87.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|